Our study offers new insights into the potential drug targets for lymphoma therapy from the perspective of substrate at amino acid level rather than CK1 itself, which is an important step toward advancing CK1‐mediated phosphorylation and phosphorylation sites of substrates to medical applications more precisely, considering the pleiotropic functions of CK1. This evidence concerns the gene CSNK1A1 and lymphoma.